BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
nitric oxide metabolic process
,
Pseudomonas infection
,
Lung
,
Amniocentesis
,
BRAF
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Pim-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Basophil of peripheral blood
Oral mucosa
T Lymphocyte (regulatory) of peripheral blood
T Lymphocyte (CD4+) of peripheral blood
Pharyngeal mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability.
Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - …
Targeting Pim kinases for cancer treatment: opportunities and challenges.
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors.
Pim Kinase Inhibitors Evaluated with a Single-Molecule Engineered Nanopore Sensor.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSP…
PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics
Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
PIM 2.0: Patient Aligned Care Team (PACT) Intensive Management (PIM) Project
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ